Envista Holdings Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Envista Holdings Corporation inventory turnover ratio, the Envista Holdings Corporation's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 4.37 in the second quarter 2026, NVST's markets remain strong, its supply chain continue to be in a grate shape.Average processing period, for Envista Holdings's inventories remained unchanged at 84 days, in the Jul 03 2026 quarter.

Within Healthcare sector 84 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2026, to 903, from total ranking in the first quarter 2026 at 986.

NVST Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Envista Holdings Corporation Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

NVST Inventory Turnover Ratio	(Jul 03 2026) II. Quarter	(Apr 03 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 26 2025) III. Quarter	(Jun 27 2025) II. Quarter
Y / Y Inventory Growth	3.19 %	14.93 %	19.54 %	9.49 %	6.86 %
Y / Y Cost of Sales Growth	3.69 %	12.5 %	21.35 %	5.65 %	1.96 %
Inventory Turnover Ratio (TTM)	4.37	4.36	4.39	4.36	4.4
NVST's Total Ranking	# 903	# 986	# 949	# 926	# 897
Average inventory processing period	84	84	83	84	83
Seq. Inventory Growth	-3.13 %	4.23 %	-0.93 %	3.16 %	7.88 %
Seq. Cost of Sales Growth	2.7 %	-7.62 %	14.05 %	-4.17 %	11.43 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 33
Healthcare Sector	# 85
Overall Market	# 903

Inventory Turnover Ratio Statistics
High	Average	Low
4.59	3.99	1.05
(Jul 02 2021)		(Sep 27 2019)

NVST Company Profile >> Back to NVST Efficiency Comparisons >> Compare NVST Inventory Turnover Ratio to its Competitors

Financial Statements
Envista Holdings's Inventories	$ 291 Millions	Visit NVST's Balance sheet
Envista Holdings's Cost of Revenues TTM	$ 1,279 Millions	Visit NVST's Income Statement
What are NVST's Sales?		Visit NVST's Sales by Segment

Other Inventory Turnover Ratios
Envista Holdings's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
NVST's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for NVST's Competitors
Inventory Turnover Ratio for NVST's Suppliers
Inventory Turnover Ratio for NVST's Customers

You may also want to know
NVST's Sales Growth Rates	NVST's Pe Price to earnings ratio	NVST's Receivables Turnover Ratio	NVST's Stock Quote
NVST's Net Income Growth Rates	NVST's Ps Price to Sales ratio	NVST's Sales per Employee	NVST's Asset Turnover Ratio
NVST's Net Margin	NVST's Pb Price to Book ratio	NVST's Financial Strength Ratios	NVST's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Jul 03 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Jul 03 2026	Inventories at quarter ending Jul 03 2026
Earth Science Tech Inc	11.64	$ 8.974 Millions	$ 1 Millions
Infusystem Holdings Inc	10.92	$ 60.985 Millions	$ 6 Millions
Irhythm Holdings Inc	10.79	$ 235.967 Millions	$ 22 Millions
Tarsus Pharmaceuticals Inc	10.20	$ 43.740 Millions	$ 4 Millions
Lantheus Holdings Inc	10.09	$ 619.325 Millions	$ 61 Millions
Sotera Health Company	10.04	$ 547.412 Millions	$ 55 Millions
Natera Inc	9.46	$ 672.186 Millions	$ 71 Millions
Warby Parker Inc	9.27	$ 414.054 Millions	$ 45 Millions
Hims and Hers Health Inc	9.23	$ 814.411 Millions	$ 88 Millions
Polomar Health Services, Inc.	8.80	$ 1.233 Millions	$ 0 Millions
Myriad Genetics Inc	8.31	$ 250.700 Millions	$ 30 Millions
National Vision Holdings Inc	8.26	$ 841.416 Millions	$ 102 Millions
Autolus Therapeutics Plc	8.08	$ 99.009 Millions	$ 12 Millions
The Oncology Institute Inc	8.03	$ 160.655 Millions	$ 20 Millions
Nutriband Inc	7.92	$ 1.082 Millions	$ 0 Millions
Novavax inc	7.61	$ 88.541 Millions	$ 12 Millions
Inogen Inc	7.51	$ 196.617 Millions	$ 26 Millions
Moderna Inc	7.50	$ 1,707.000 Millions	$ 228 Millions
Cardiff Lexington Corporation	7.49	$ 4.042 Millions	$ 1 Millions
Pulse Biosciences Inc	7.45	$ 1.182 Millions	$ 0 Millions
Vanda Pharmaceuticals Inc	7.43	$ 13.506 Millions	$ 2 Millions
Carlsmed Inc	7.42	$ 13.955 Millions	$ 2 Millions
Adaptive Biotechnologies Corporation	7.26	$ 75.254 Millions	$ 10 Millions
Lifemd Inc	7.22	$ 22.284 Millions	$ 3 Millions
Brightspring Health Services Inc	6.35	$ 4,108.953 Millions	$ 647 Millions
Puma Biotechnology Inc	6.29	$ 58.199 Millions	$ 9 Millions
Adm Tronics Unlimited Inc	6.05	$ 1.970 Millions	$ 0 Millions
Sharps Technology Inc	5.68	$ 2.869 Millions	$ 1 Millions
Transmedics Group Inc	5.59	$ 276.120 Millions	$ 49 Millions
Cg Oncology Inc	5.47	$ 7.609 Millions	$ 1 Millions

Date modified: 2026-09-08T15:11:45+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.